HeartSciences Launches MyoVista Insights Version 1.3 with FDA-Cleared AI-ECG Algorithm Marketplace
HeartSciences Inc. has launched version 1.3 of its platform, introducing an AI-ECG algorithm marketplace featuring the first FDA-cleared ECG-EF algorithm from Bunkerhill Health for detecting reduced ejection fraction. This update supports a recurring SaaS-based revenue model and aims to expand with additional third-party algorithms.
Topics: AI-ECG algorithm marketplace FDA clearance SaaS platform